Atrial Fibrillation Clinical Trials in Rimini
2 recruitingRimini, Italy
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Anthos Therapeutics, Inc.1,900 enrolled721 locationsNCT05712200
Recruiting
ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing
Atrial FibrillationVentricular DysfunctionArrhythmias, Cardiac+22 more
University Hospital of Ferrara8,400 enrolled31 locationsNCT06324682